Genistein may up-regulate the expression of the tumor suppressor miR-574-3p in clinical prostate cancer samples and prostate cancer cell lines, thereby causing apoptosis through Bcl-xL, caspase-9 and caspase-3 pathways regulation [148]. Here, BCL2L1 is linked to prostate carcinoma.